200 related articles for article (PubMed ID: 2504232)
1. Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.
Fuchs D; Chiodi F; Albert J; Asjö B; Hagberg L; Hausen A; Norkrans G; Reibnegger G; Werner ER; Wachter H
AIDS; 1989 May; 3(5):285-8. PubMed ID: 2504232
[TBL] [Abstract][Full Text] [Related]
2. Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.
Sönnerborg AB; von Stedingk LV; Hansson LO; Strannegård OO
AIDS; 1989 May; 3(5):277-83. PubMed ID: 2504231
[TBL] [Abstract][Full Text] [Related]
3. Study of beta-2 microglobulin and neopterin in serum and cerebrospinal fluid of HIV-infected patients.
Imberciadori G; Piersantelli N; Bo A; Calderisi S; Emanuelli F; Marchetto E; Penco G; Farinelli M; Arata L; Ribizzi G
Acta Neurol (Napoli); 1990 Feb; 12(1):58-61. PubMed ID: 2186603
[No Abstract] [Full Text] [Related]
4. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
Neurology; 1991 Jan; 41(1):69-74. PubMed ID: 1898675
[TBL] [Abstract][Full Text] [Related]
5. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status.
Lucey DR; McGuire SA; Abbadessa S; Hall K; Woolford B; Valtier S; Butzin CA; Melcher GP; Hendrix CW
Viral Immunol; 1993; 6(4):267-72. PubMed ID: 7909441
[TBL] [Abstract][Full Text] [Related]
7. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms.
Fuchs D; Möller AA; Reibnegger G; Stöckle E; Werner ER; Wachter H
J Acquir Immune Defic Syndr (1988); 1990; 3(9):873-6. PubMed ID: 2166783
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid and serum neopterin levels in patients with Lyme neuroborreliosis.
Dotevall L; Fuchs D; Reibnegger G; Wachter H; Hagberg L
Infection; 1990; 18(4):210-4. PubMed ID: 2210852
[TBL] [Abstract][Full Text] [Related]
9. Immune activation and decreased tryptophan in patients with HIV-1 infection.
Fuchs D; Forsman A; Hagberg L; Larsson M; Norkrans G; Reibnegger G; Werner ER; Wachter H
J Interferon Res; 1990 Dec; 10(6):599-603. PubMed ID: 2128302
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
[TBL] [Abstract][Full Text] [Related]
11. [Cerebrospinal fluid neopterin levels in children with neurologic diseases].
Nakazawa T
No To Hattatsu; 1996 Jul; 28(4):291-8. PubMed ID: 8753127
[TBL] [Abstract][Full Text] [Related]
12. Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals.
Ali A; Rudge P; Dalgleish AG
J Neurol; 1992 May; 239(5):270-2. PubMed ID: 1607890
[TBL] [Abstract][Full Text] [Related]
13. Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production.
Fuchs D; Shearer GM; Boswell RN; Clerici M; Reibnegger G; Werner ER; Zajac RA; Wachter H
Clin Exp Immunol; 1990 Apr; 80(1):44-8. PubMed ID: 1969780
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid and serum neopterin and biopterin in D-retrovirus-infected rhesus macaques (Macaca mulatta): relationship to clinical and viral status.
Heyes MP; Lackner A; Kaufman S; Milstien S
AIDS; 1991 May; 5(5):555-60. PubMed ID: 1863408
[TBL] [Abstract][Full Text] [Related]
15. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases.
Heidenreich F; Arendt G; Jander S; Jablonowski H; Stoll G
J Neuroimmunol; 1994 Jul; 52(2):117-26. PubMed ID: 7913474
[TBL] [Abstract][Full Text] [Related]
16. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users.
Sacktor N; Liu X; Popescu M; Marder K; Stern Y; Mayeux R
Arch Neurol; 1995 Jul; 52(7):676-9. PubMed ID: 7619023
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.
Fredrikson S; Eneroth P; Link H
Clin Exp Immunol; 1987 Jan; 67(1):76-81. PubMed ID: 3621676
[TBL] [Abstract][Full Text] [Related]
18. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.
Gisslén M; Chiodi F; Fuchs D; Norkrans G; Svennerholm B; Wachter H; Hagberg L
Scand J Infect Dis; 1994; 26(5):523-33. PubMed ID: 7855550
[TBL] [Abstract][Full Text] [Related]
19. Significance of CSF total neopterin and biopterin in inflammatory neurological diseases.
Furukawa Y; Nishi K; Kondo T; Tanabe K; Mizuno Y
J Neurol Sci; 1992 Aug; 111(1):65-72. PubMed ID: 1402999
[TBL] [Abstract][Full Text] [Related]
20. CSF neopterin as marker of disease activity in multiple sclerosis.
Fredrikson S; Link H; Eneroth P
Acta Neurol Scand; 1987 May; 75(5):352-5. PubMed ID: 3618112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
